Sign in
4

Changes in Ownership

Gain Therapeutics, Inc. Filed Acc 0001493152-24-012340

Director bought 30,000 shares at $3.86 ($115,770)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Riley Jeffrey Scott Director 2024-03-28 Purchase +30,000 $3.86 $115,770 30,000 D: show line 1 in the form
Open-market purchases · 30,000 sh · avg $3.86 · $115,770
Loading xslF345X05/ownership.xml…